Literature DB >> 27371361

Complement research in the 18th-21st centuries: Progress comes with new technology.

R B Sim1, W Schwaeble2, T Fujita3.   

Abstract

The complement system has been studied for about 120 years. Progress in defining this large and complex system has been dependent on the research technologies available, but since the introduction of protein chromatography, electrophoresis, and antibody-based assay methods in the 1950s and 60s, and sequencing of proteins and DNA in the 70s and 80s, there has been very rapid accumulation of data. With more recent improvements in 3D structure determination (nmr and X-ray crystallography), the structures of most of the complement proteins have now been solved. Complement research since 1990 has been greatly stimulated by the discoveries of the multiple proteins in the lectin pathway, the strong association of Factor H, C3, Factor B allelic variants with adult macular degeneration and atypical haemolytic uremic syndrome, and the introduction of the anti-C5 monoclonal antibody as a therapy for paroxysmal nocturnal hemoglobinuria and atypical haemolytic uremic syndrome. Potential new roles for complement in tissue development and the search for novel therapeutics suggest a very active future for complement research.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Alternative pathway; Complement; History; Innate immunity; Lectin pathway

Mesh:

Substances:

Year:  2016        PMID: 27371361     DOI: 10.1016/j.imbio.2016.06.011

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  9 in total

Review 1.  Complement and the Kidney: An Overview.

Authors:  Joshua M Thurman
Journal:  Adv Chronic Kidney Dis       Date:  2020-03       Impact factor: 3.620

Review 2.  C1q: A fresh look upon an old molecule.

Authors:  Nicole M Thielens; Francesco Tedesco; Suzanne S Bohlson; Christine Gaboriaud; Andrea J Tenner
Journal:  Mol Immunol       Date:  2017-06-07       Impact factor: 4.407

3.  Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis.

Authors:  Sandhya Xavier; Ranjit K Sahu; Susan G Landes; Jing Yu; Ronald P Taylor; Srinivas Ayyadevara; Judit Megyesi; William B Stallcup; Jeremy S Duffield; Edimara S Reis; John D Lambris; Didier Portilla
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-04

Review 4.  The complement system: an evolution in progress.

Authors:  Berhane Ghebrehiwet
Journal:  F1000Res       Date:  2016-12-12

Review 5.  Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage.

Authors:  Rossana Franzin; Alessandra Stasi; Marco Fiorentino; Giovanni Stallone; Vincenzo Cantaluppi; Loreto Gesualdo; Giuseppe Castellano
Journal:  Front Immunol       Date:  2020-05-07       Impact factor: 7.561

6.  A novel approach to immunoapheresis of C3a/C3 and proteomic identification of associates.

Authors:  Wolfgang Winnicki; Peter Pichler; Karl Mechtler; Richard Imre; Ines Steinmacher; Gürkan Sengölge; Daniela Knafl; Georg Beilhack; Ludwig Wagner
Journal:  PeerJ       Date:  2019-12-16       Impact factor: 2.984

7.  Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple Species.

Authors:  Wioleta M Zelek; B Paul Morgan
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 8.786

8.  Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Authors:  Peter Garred; Andrea J Tenner; Tom E Mollnes
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 9.  Emerging Roles of Complement in Psychiatric Disorders.

Authors:  Mélanie Druart; Corentin Le Magueresse
Journal:  Front Psychiatry       Date:  2019-08-21       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.